Folegatti PM, Pepin S, Tabar C, et al. Comparative assessment of immunogenicity and safety of recombinant influenza vaccine in children, adolescents, and adults: Results from a phase 3, immunobridging, open-label, non-randomised study. Lancet Infect Dis. Published online May 21, 2025. doi:10.1016/S1473-3099(25)00153-7
Source link : https://www.medscape.com/viewarticle/recombinant-flu-shots-extend-protection-children-2025a1000e79?src=rss
Author :
Publish date : 2025-06-02 12:00:00
Copyright for syndicated content belongs to the linked Source.